BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 31926332)

  • 1. Cysteinyl cathepsins in cardiovascular diseases.
    Zhang X; Luo S; Wang M; Shi GP
    Biochim Biophys Acta Proteins Proteom; 2020 Apr; 1868(4):140360. PubMed ID: 31926332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials.
    Liu CL; Guo J; Zhang X; Sukhova GK; Libby P; Shi GP
    Nat Rev Cardiol; 2018 Jun; 15(6):351-370. PubMed ID: 29679024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis?
    Sukhova GK; Shi GP
    Ann N Y Acad Sci; 2006 Nov; 1085():161-9. PubMed ID: 17182932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.
    Wu H; Du Q; Dai Q; Ge J; Cheng X
    J Atheroscler Thromb; 2018 Feb; 25(2):111-123. PubMed ID: 28978867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin cysteine proteases in cardiovascular disease.
    Lutgens SP; Cleutjens KB; Daemen MJ; Heeneman S
    FASEB J; 2007 Oct; 21(12):3029-41. PubMed ID: 17522380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.
    Qin Y; Shi GP
    Pharmacol Ther; 2011 Sep; 131(3):338-50. PubMed ID: 21605595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.
    Cheng XW; Huang Z; Kuzuya M; Okumura K; Murohara T
    Hypertension; 2011 Dec; 58(6):978-86. PubMed ID: 21986502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine protease activity in the wall of abdominal aortic aneurysms.
    Abisi S; Burnand KG; Waltham M; Humphries J; Taylor PR; Smith A
    J Vasc Surg; 2007 Dec; 46(6):1260-6. PubMed ID: 18155003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C: an emerging biomarker in cardiovascular disease.
    Angelidis C; Deftereos S; Giannopoulos G; Anatoliotakis N; Bouras G; Hatzis G; Panagopoulou V; Pyrgakis V; Cleman MW
    Curr Top Med Chem; 2013; 13(2):164-79. PubMed ID: 23470076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin S is associated with degradation of collagen I in abdominal aortic aneurysm.
    Klaus V; Schmies F; Reeps C; Trenner M; Geisbüsch S; Lohoefer F; Eckstein HH; Pelisek J
    Vasa; 2018 Jun; 47(4):285-293. PubMed ID: 29624112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.
    Qin Y; Cao X; Yang Y; Shi GP
    Future Cardiol; 2013 Jan; 9(1):89-103. PubMed ID: 23259477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.
    Li X; Liu Z; Cheng Z; Cheng X
    Chonnam Med J; 2012 Aug; 48(2):77-85. PubMed ID: 22977747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cells and cathepsins: Biochemical and biomechanical regulation.
    Platt MO; Shockey WA
    Biochimie; 2016 Mar; 122():314-23. PubMed ID: 26458976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Key Role of Lysosomal Protease Cathepsins in Viral Infections.
    Scarcella M; d'Angelo D; Ciampa M; Tafuri S; Avallone L; Pavone LM; De Pasquale V
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012353
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yadati T; Houben T; Bitorina A; Shiri-Sverdlov R
    Cells; 2020 Jul; 9(7):. PubMed ID: 32668602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine proteases in atherosclerosis.
    Weiss-Sadan T; Gotsman I; Blum G
    FEBS J; 2017 May; 284(10):1455-1472. PubMed ID: 28207191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm.
    Sjöberg S; Shi GP
    Clin Rev Bone Miner Metab; 2011 Jun; 9(2):138-147. PubMed ID: 22505840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics.
    Haque A; Banik NL; Ray SK
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):270-7. PubMed ID: 18673211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsins Drive Anti-Inflammatory Activity by Regulating Autophagy and Mitochondrial Dynamics in Macrophage Foam Cells.
    Weiss-Sadan T; Maimoun D; Oelschlagel D; Kaschani F; Misiak D; Gaikwad H; Ben-Nun Y; Merquiol E; Anaki A; Tsvirkun D; Kaiser M; Michl P; Gotsman I; Blum G
    Cell Physiol Biochem; 2019; 53(3):550-572. PubMed ID: 31529928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsins and cystatin C in atherosclerosis and obesity.
    Lafarge JC; Naour N; Clément K; Guerre-Millo M
    Biochimie; 2010 Nov; 92(11):1580-6. PubMed ID: 20417681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.